August 26, 2016
A New Jersey federal judge agreed Thursday to dismiss Gilead Sciences Inc. and Emory University's suit alleging Indian drugmaker Hetero Drugs Ltd. infringed four patents for HIV treatment Truvada by seeking U.S. Food and Drug Administration approval to make a generic of the drug.
August 12, 2016
Gilead Sciences Inc. and Emory University on Thursday accused Indian drugmaker Hetero Drugs Ltd. in New Jersey federal court of infringing four patents for the HIV treatment Truvada by applying to make a generic with the U.S. Food and Drug Administration.